Challenges in reducing dengue burden; diagnostics, control measures and vaccines

Area of Science:

• Public Health
• Infectious Diseases
• Vaccinology

Background:

• Dengue fever is a growing global health threat, disproportionately affecting resource-limited developing nations.
• Current dengue treatment is supportive, and vector control methods are often insufficient, highlighting the need for effective vaccines.
• The economic and human toll of dengue necessitates urgent development of preventative measures.

Purpose of the Study:

• To review the current status of dengue epidemiology, disease burden, and pathogenesis.
• To examine promising dengue vaccine candidates in clinical development.
• To discuss considerations for dengue vaccine introduction and cost-effectiveness.

Main Methods:

• Literature review of dengue epidemiology, pathogenesis, and vaccine development.
• Analysis of clinical trial data for leading dengue vaccine candidates.
• Economic evaluation of vaccination programs versus vector control.

Main Results:

• Several dengue vaccine candidates show promise, with a leading tetravalent, live attenuated, recombinant vaccine in Phase III trials.
• Vaccination programs are anticipated to be as cost-effective as current vector control strategies.
• Dengue vaccine development faces challenges but offers a critical public health solution.

Conclusions:

• A dengue vaccine is an urgent necessity given the increasing global incidence and burden of the disease.
• Promising vaccine candidates are advancing, offering hope for effective dengue prevention.
• Successful dengue vaccine introduction requires careful planning and consideration of various factors.